Breast Cancer Clinical Trial
Official title:
Influence of Fibrin Glue on Seroma Formation After Modified Radical
This study was carried out from January 2005 to December 2007 at Mansoura university hospital. Fifty patients who had breast cancer were included in the study, MRM was done for all patients. Patients were randomly divided into two groups. Group І with fibrin glue 4ml of fibrin glue was sprayed on the surgical area with Y canula and group П without fibrin glue. Preoperative, Operative and Postoperative data were collected including postoperative measurement of drainage, date of removal of the drain, state of the wound, incidence of Seroma formation.
This study was carried out from January 2005 to December 2007 at Mansoura university
hospital, Departement 8 of surgical department. This study approved by local ethical
committee Fifty patients had breast cancer were included in the study. Patients who received
preoperative chemotherapy and radiotherapy were exclude Also, patients with previous
axillary surgery or patients who underwent simultaneous reconstructive surgery and breast
conservative surgery and locally advanced breast cancer were exclude.
Informed written consent was obtained from all patients included in the study. All patients
include in the study, MRM was done for then and axillary lymphadenectomy extended to the
axillary level III was done with sharp dissection and ligation of the visible lymph vessels
and minor blood vessel. After performing hemostasis in the mastectomy and axillary area.
.Patients were randomly divided by closed envelop into two groups. Patients were randomized
at end of surgical procedure to avoid possible treatment bias during surgical procedure.
Group І (with fibrin glue) and group П without fibrin glue. In fibrin glue group. 4 ml of
fibrin glue was sprayed on the surgical area with Y canula (doubleject application system).
In group 11 after good haemostasis the same sized drain was applied in axillary and breast
area and incision was closed. Followed by external compression for 10 minutes in both
groups. Drains were left in places until the drainage for the preceding 24 h was less than
30 ml/day.
Data collected Preoperative data collected included age, body mass indexed (BMI), medical
and surgical history, history of chemotherapy, radiotherapy Operative data included
estimated blood loss, types of dissection, duration of the operation Postoperative data
included hospital stay , postoperative measurement of drainage daily , date of removal ,
state of the wound ( infection , haematoma, necrosis , opened wound ), number of axillary
lymph nodes dissected , cancer stage , number of axillary lymph nodes positive, incidence of
Seroma formation , interval of Seroma resolution , Seroma aspirated volume and number of
postoperative visits Seroma formation was defined as inability to remove participant drain
by postoperative day 10 because of high output (more than 30 ml /day drain Seroma) and / or
the need to aspirate of fluid after removal of the drain.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |